PDX-200 & PDX-CV Tablets | Cefpodoxime Proxetil 200mg

PDX-200 & PDX-CV Tablets contain Cefpodoxime Proxetil, a third-generation oral cephalosporin antibiotic, designed for effective treatment of a wide range of bacterial infections. The PDX-CV variant combines Cefpodoxime with Clavulanic Acid to enhance activity against resistant bacteria.

This formulation provides broad-spectrum antibacterial coverage against Gram-positive and Gram-negative organisms. It is highly effective in treating respiratory, urinary, skin, and soft tissue infections, offering improved clinical outcomes in difficult and resistant infections.

🔹 Key Benefits

• Broad-spectrum antibacterial activity

• Effective against Gram-positive and Gram-negative bacteria

• Clavulanic acid enhances action against resistant strains

• High oral bioavailability with good tissue penetration

• Reduces treatment failure in resistant infections

• Convenient dosing improves patient compliance

🔹 Indications

• Upper and lower respiratory tract infections

• ENT infections

• Urinary tract infections

• Skin and soft tissue infections

• Community-acquired bacterial infections